In this video, Tanya Dorff, MD discusses the current state of the pipeline for developing castration-resistant prostate cancer treatments.

In this video, Tanya Dorff, MD discusses the latest advancements in the study and treatment of castration-resistant prostate cancer.

Beyoncé’s dad teamed up with ZERO Prostate Cancer to tackle the disease. Learn how this game-changing campaign is breaking stigma, expanding screenings and saving lives.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

A new at-home urine test for prostate cancer developed by Michigan researchers aims to encourage more men to undergo ...

Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...

Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...